Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 961

1.

Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.

Alvarez XA, Mouzo R, Pichel V, Pérez P, Laredo M, Fernández-Novoa L, Corzo L, Zas R, Alcaraz M, Secades JJ, Lozano R, Cacabelos R.

Methods Find Exp Clin Pharmacol. 1999 Nov;21(9):633-44.

PMID:
10669911
[PubMed - indexed for MEDLINE]
2.

Double-blind, randomized, placebo-controlled pilot study with anapsos in senile dementia: effects on cognition, brain bioelectrical activity and cerebral hemodynamics.

Alvarez XA, Pichel V, Pérez P, Laredo M, Corzo D, Zas R, Fernández-Novoa L, Sempere JM, Díaz J, Cacabelos R.

Methods Find Exp Clin Pharmacol. 2000 Sep;22(7):585-94.

PMID:
11196347
[PubMed - indexed for MEDLINE]
4.

Optimal dosing of galantamine in patients with mild or moderate Alzheimer's disease: post Hoc analysis of a randomized, double-blind, placebo-controlled trial.

Aronson S, Van Baelen B, Kavanagh S, Schwalen S.

Drugs Aging. 2009;26(3):231-9. doi: 10.2165/00002512-200926030-00004.

PMID:
19358618
[PubMed - indexed for MEDLINE]
5.

Apolipoprotein E genotype and gender influence response to tacrine therapy.

Farlow MR, Lahiri DK, Poirier J, Davignon J, Hui S.

Ann N Y Acad Sci. 1996 Dec 16;802:101-10.

PMID:
8993489
[PubMed - indexed for MEDLINE]
6.

Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study.

Doody RS, Gavrilova SI, Sano M, Thomas RG, Aisen PS, Bachurin SO, Seely L, Hung D; dimebon investigators.

Lancet. 2008 Jul 19;372(9634):207-15. doi: 10.1016/S0140-6736(08)61074-0.

PMID:
18640457
[PubMed - indexed for MEDLINE]
7.

A double-blind, placebo-controlled, multicenter study of Cerebrolysin for Alzheimer's disease.

Bae CY, Cho CY, Cho K, Hoon Oh B, Choi KG, Lee HS, Jung SP, Kim DH, Lee S, Choi GD, Cho H, Lee H.

J Am Geriatr Soc. 2000 Dec;48(12):1566-71.

PMID:
11129744
[PubMed - indexed for MEDLINE]
8.
9.

Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial.

Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi AH, Khani M.

J Clin Pharm Ther. 2003 Feb;28(1):53-9.

PMID:
12605619
[PubMed - indexed for MEDLINE]
10.

Citicoline: pharmacological and clinical review, 2006 update.

Secades JJ, Lorenzo JL.

Methods Find Exp Clin Pharmacol. 2006 Sep;28 Suppl B:1-56. Review.

PMID:
17171187
[PubMed - indexed for MEDLINE]
11.

Functional, cognitive and behavioral effects of donepezil in patients with moderate Alzheimer's disease.

Gauthier S, Feldman H, Hecker J, Vellas B, Emir B, Subbiah P; Donepezil MSAD Study Investigators' Group.

Curr Med Res Opin. 2002;18(6):347-54.

PMID:
12442882
[PubMed - indexed for MEDLINE]
13.

Therapeutic effects of CDP-choline in Alzheimer's disease. Cognition, brain mapping, cerebrovascular hemodynamics, and immune factors.

Cacabelos R, Caamaño J, Gómez MJ, Fernández-Novoa L, Franco-Maside A, Alvarez XA.

Ann N Y Acad Sci. 1996 Jan 17;777:399-403.

PMID:
8624120
[PubMed - indexed for MEDLINE]
14.

Assessing therapeutic efficacy in a progressive disease: a study of donepezil in Alzheimer's disease.

Johannsen P, Salmon E, Hampel H, Xu Y, Richardson S, Qvitzau S, Schindler R; AWARE Study Group.

CNS Drugs. 2006;20(4):311-25. Erratum in: CNS Drugs. 2006;20(10):866.

PMID:
16599649
[PubMed - indexed for MEDLINE]
15.

A randomized efficacy trial of citicoline in patients with acute ischemic stroke.

Clark WM, Williams BJ, Selzer KA, Zweifler RM, Sabounjian LA, Gammans RE.

Stroke. 1999 Dec;30(12):2592-7.

PMID:
10582983
[PubMed - indexed for MEDLINE]
Free Article
16.

Brain mapping activity and mental performance after chronic treatment with CDP-choline in Alzheimer's disease.

Franco-Maside A, Caamaño J, Gómez MJ, Cacabelos R.

Methods Find Exp Clin Pharmacol. 1994 Oct;16(8):597-607.

PMID:
7760585
[PubMed - indexed for MEDLINE]
17.

"Brain-specific" nutrients: a memory cure?

McDaniel MA, Maier SF, Einstein GO.

Nutrition. 2003 Nov-Dec;19(11-12):957-75. Review.

PMID:
14624946
[PubMed - indexed for MEDLINE]
18.

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group.

Rogers SL, Farlow MR, Doody RS, Mohs R, Friedhoff LT.

Neurology. 1998 Jan;50(1):136-45.

PMID:
9443470
[PubMed - indexed for MEDLINE]
19.

Safety and tolerability of donepezil at doses up to 20 mg/day: results from a pilot study in patients with Alzheimer's disease.

Doody RS, Corey-Bloom J, Zhang R, Li H, Ieni J, Schindler R.

Drugs Aging. 2008;25(2):163-74.

PMID:
18257603
[PubMed - indexed for MEDLINE]
20.

CDP-choline: pharmacological and clinical review.

Secades JJ, Frontera G.

Methods Find Exp Clin Pharmacol. 1995 Oct;17 Suppl B:1-54. Review.

PMID:
8709678
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk